Novartis Updates Medium-term Guidance

MT Newswires · 2d ago
01:24 AM EST, 11/19/2026 (MT Newswires) -- Novartis (NOVN.SW) updated its guidance for the medium term covering 2026 to 2031, according to a Thursday release. The Swiss drugmaker expects net sales to grow at a compound annual growth rate of 5% in constant currencies during the period.